Widespread use of current technologies 'essential' to improve global health

Published on August 3, 2012 at 12:19 PM · No Comments

Noting that this week's issue of the Lancet explores the theme of "[a]ccess to beneficial health technology, including essential medicines and medical devices, for those most in need," a Lancet editorial states, "Maximizing use of current health technologies (drugs, devices, biological products, medical and surgical procedures, support systems, and organizational systems) is essential to improving global health." Collaboration between the journal and Imperial College London has resulted in a new Commission on technologies for global health, which examines different ways to broaden the use of new technologies, from bringing down cost to making them more culturally acceptable, the editorial notes.

"Technologies do not have to be specifically designed for health purposes to have an effect," the editorial continues, noting that information technology, distribution innovations, and "wider technologies associated with improving road safety, sanitation, and food supplies are crucial to improve health for all" (8/1). An executive summary of the commission's report, as well as a video interview with lead author Peter Howitt, are available online from the Lancet (8/1).

    http://www.kaiserhealthnews.orgThis article was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Device / Technology News | Healthcare News

    Tags: , ,

    Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
    Post a new comment
    You might also like... ×
    TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage